Immunome Inc
NASDAQ:IMNM

Watchlist Manager
Immunome Inc Logo
Immunome Inc
NASDAQ:IMNM
Watchlist
Price: 9.2 USD -6.03% Market Closed
Market Cap: 800.5m USD

Wall Street
Price Targets

IMNM Price Targets Summary
Immunome Inc

Wall Street analysts forecast IMNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMNM is 24.99 USD with a low forecast of 20.2 USD and a high forecast of 39.9 USD.

Lowest
Price Target
20.2 USD
120% Upside
Average
Price Target
24.99 USD
172% Upside
Highest
Price Target
39.9 USD
334% Upside
Immunome Inc Competitors:
Price Targets
2480
Beijing Luzhu Biotechnology Co Ltd
38% Upside
CPRX
Catalyst Pharmaceuticals Inc
47% Upside
4587
PeptiDream Inc
120% Upside
BPMC
Blueprint Medicines Corp
0% Downside
RCUS
Arcus Biosciences Inc
211% Upside
ZEAL
Zealand Pharma A/S
104% Upside
SRZN
Surrozen Inc
298% Upside
CDNA
CareDx Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Immunome Inc

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is 101%.

N/A
Past Growth
101%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMNM's stock price target?
Price Target
24.99 USD

According to Wall Street analysts, the average 1-year price target for IMNM is 24.99 USD with a low forecast of 20.2 USD and a high forecast of 39.9 USD.

What is Immunome Inc's Revenue forecast?
Projected CAGR
101%

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is 101%.

Back to Top